Author:
Shtrygol Sergiy,Zalevskyi Sergiy,Mishchenko Mariia,Shtrygol Diana,Severina Hanna,Kayal Wassim El,Georgiyants Victoriya
Abstract
https://www.prolekare.cz/en/journals/czech-and-slovak-pharmacy/2022-5-7/promising-anticonvulsant-n-2-4-dichlorophenyl-methyl-2-2-4-dioxo-1h-quinazolin-3-yl-acetamide-dose-dependent-study-and-evaluation-of-anticonvulsant-action-spectrum-in-vivo-and-in-silico-132621
Reference24 articles.
1. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic Drugs: a 30-year longitudinal cohort study;Chen;JAMA Neurol,2018
2. 2. Bigelow M. D., Kouzani A. Z. Neural stimulation systems for the control of refractory epilepsy: a review. J. Neuroeng. Rehabil. 2019; 16(1): 126.
3. 3. El Kayal W. M., Mokhamad W., Shtrygol S. Yu., Zalevskyi S. V., Abu Shark A., Tsyvunin V. V., Kovalenko S. M., Bunyatyan N. D., Perekhoda L. O., Severina H. I., Georgiyants V. A. Synthesis, in vivo and in silico anticonvulsant activity studies of new derivatives of 2-(2,4-dioxo- 1,4-dihydroquinazolin-3(2H)-yl)acetamide. Eur. J. Med. Chem. 2019; 180(15): 134-142.
4. 4. Bunyatyan N. D., Severina H. I., El Kayal W. M., Zalevskyi S. V., Shtrygol S. Yu., Abu Shark A., Tsyvunin V. V., Kompantsev D. V., Shevchenko A. M., Kovalenko S. N., Georgiyants V. A., Ogay M. A., Khadzhieva Z. J. Synthesis and anticonvulsant activity of new 2-(4-oxo-2-thioxo-1,4-dihydro-3(2H)quinazolinyl)acetamides. Pharm. Chem. J. 2020; 54(1): 1-8.
5. 5. Zalevskyi S. V., Shtrygol' S. Yu., Shtrygol' D. V. Psychotropic properties and acute toxicity of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-[(2,4-dichlorophenylmethyl]- acetamide - a promising anticonvulsant. Pharm. & Drug Toxic. 2021; 15(6): 363-371.